Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Ana B Herrero"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Deletions of chromosome 1p (del(1p)) are a recurrent genomic aberration associated with poor outcome in Multiple myeloma (MM.) TRIM33, an E3 ligase and transcriptional co-repressor, is located within a commonly deleted region at 1p13.2. TRIM
Externí odkaz:
https://doaj.org/article/43685fcf2e784080aa0b53d8bebdb850
Autor:
Dalia Quwaider, Luis A. Corchete, Marta Martín-Izquierdo, Jesús M. Hernández-Sánchez, Elizabeta A. Rojas, Ignacio J. Cardona-Benavides, Ramón García-Sanz, Ana B. Herrero, Norma C. Gutiérrez
Publikováno v:
Experimental Hematology & Oncology, Vol 11, Iss 1, Pp 1-15 (2022)
Abstract Background IRE1 is an unfolded protein response (UPR) sensor with kinase and endonuclease activity. It plays a central role in the endoplasmic reticulum (ER) stress response through unconventional splicing of XBP1 mRNA and regulated IRE1-dep
Externí odkaz:
https://doaj.org/article/409d0ac1f36745b8828aeaa0a297b3ca
Autor:
Ana-Alicia López-Iglesias, Ana B. Herrero, Marta Chesi, Laura San-Segundo, Lorena González-Méndez, Susana Hernández-García, Irena Misiewicz-Krzeminska, Dalia Quwaider, Montserrat Martín-Sánchez, Daniel Primo, Teresa Paíno, P. Leif Bergsagel, Thomas Mehrling, Marcos González-Díaz, Jesús F. San-Miguel, María-Victoria Mateos, Norma C. Gutiérrez, Mercedes Garayoa, Enrique M. Ocio
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-14 (2017)
Abstract Background Despite recent advances in the treatment of multiple myeloma (MM), the prognosis of most patients remains poor, and resistance to traditional and new drugs frequently occurs. EDO-S101 is a novel therapeutic agent conceived as the
Externí odkaz:
https://doaj.org/article/bfebf6dd497c42b797a071d86cc0e1d4
Autor:
Dalia Quwaider, Luis A. Corchete, Irena Misiewicz-Krzeminska, María E. Sarasquete, José J. Pérez, Patryk Krzeminski, Noemí Puig, María Victoria Mateos, Ramón García-Sanz, Ana B. Herrero, Norma C. Gutiérrez
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-12 (2017)
Abstract Background The B cell maturation process involves multiple steps, which are controlled by relevant pathways and transcription factors. The understanding of the final stages of plasma cell (PC) differentiation could provide new insights for t
Externí odkaz:
https://doaj.org/article/8c10825ddb1c4a2f8a9ac6c1204e58cd
Autor:
Sergio Moreno, Jesús Balsinde, Carmen Cuevas, María A. Balboa, Alma M. Astudillo, Ana B. Herrero
Supplementary Table 1 from Levels of SCS7/FA2H-Mediated Fatty Acid 2-Hydroxylation Determine the Sensitivity of Cells to Antitumor PM02734
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01804be1b16bc786f57dbd61862b7413
https://doi.org/10.1158/0008-5472.22375962
https://doi.org/10.1158/0008-5472.22375962
Autor:
Sergio Moreno, Jesús Balsinde, Carmen Cuevas, María A. Balboa, Alma M. Astudillo, Ana B. Herrero
Supplementary Table 3 from Levels of SCS7/FA2H-Mediated Fatty Acid 2-Hydroxylation Determine the Sensitivity of Cells to Antitumor PM02734
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f494f15c96037d841868fcd5b87ac35
https://doi.org/10.1158/0008-5472.22375956.v1
https://doi.org/10.1158/0008-5472.22375956.v1
Autor:
Sergio Moreno, Jesús Balsinde, Carmen Cuevas, María A. Balboa, Alma M. Astudillo, Ana B. Herrero
Supplementary Data from Levels of SCS7/FA2H-Mediated Fatty Acid 2-Hydroxylation Determine the Sensitivity of Cells to Antitumor PM02734
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd40f92ee7e8c94c7017fe49301db228
https://doi.org/10.1158/0008-5472.22375968.v1
https://doi.org/10.1158/0008-5472.22375968.v1
Trabectedin (Yondelis) is a potent antitumor drug that has the unique characteristic of killing cells by poisoning the DNA nucleotide excision repair (NER) machinery. The basis for the NER-dependent toxicity has not yet been elucidated but it has bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b26d4010d90ae2ef3a0348aec14c091
https://doi.org/10.1158/0008-5472.c.6494520
https://doi.org/10.1158/0008-5472.c.6494520
Supplementary Table S1, Methods and Materials from Cross-Talk between Nucleotide Excision and Homologous Recombination DNA Repair Pathways in the Mechanism of Action of Antitumor Trabectedin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d5a25615d48a3a6a53b55c666c4fbc9
https://doi.org/10.1158/0008-5472.22365069.v1
https://doi.org/10.1158/0008-5472.22365069.v1
Supplementary Figure S2 from Cross-Talk between Nucleotide Excision and Homologous Recombination DNA Repair Pathways in the Mechanism of Action of Antitumor Trabectedin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::654729656fd7c1494075ba7f746bc4d2
https://doi.org/10.1158/0008-5472.22365072.v1
https://doi.org/10.1158/0008-5472.22365072.v1